New Key Statistics Module, Z-Score and F-Score
OTCPK:RNLXY Key Ratios
Market Cap $ M | 19.71 |
Enterprise Value $ M | 23.57 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 4.71 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2.00 |
EPS (TTM) $ | -0.64 |
Beneish M-Score | -3.81 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 8.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.77 |
EV-to-EBITDA | -0.81 |
PEG | -- |
Shares Outstanding M | 94.97 |
Net Margin (%) | -1,493.22 |
Operating Margin % | -1,293.60 |
Pre-tax Margin (%) | -1,493.22 |
Quick Ratio | 0.53 |
Current Ratio | 0.53 |
ROA % (ttm) | -192.02 |
ROE % (ttm) | -- |
ROIC % (ttm) | -189.04 |
Dividend Yield % | -- |
Altman Z-Score | -51.24 |
RNLXY Number of Guru Trades
RNLXY Volume of Guru Trades
Gurus Latest Trades with OTCPK:RNLXY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RNLXY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Renalytix PLC Insider Transactions
No Available Data
News about OTCPK:RNLXY
Total 0- 1